| Name | Title | Contact Details |
|---|---|---|
Richard Dilgren |
Chief Technology Officer | Profile |
Fujitsu Limited is a Japanese multinational information and communications technology equipment and services company, established in 1935 and headquartered in Tokyo.
Global Scheduling Solutions is a Hauppauge, NY-based company in the Software and Internet sector.
Verse offers a unique blend of 2-way AI-driven follow-up via SMS and by highly trained representatives.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Yardbarker is a San Francisco, CA-based company in the Software and Internet sector.